Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

AI Tool Accurately Sorts Cancer Patients by Likely Outcomes

By HospiMedica International staff writers
Posted on 15 May 2025

Pharmaceutical companies and healthcare providers often face the challenge of determining which patients will respond most effectively to a given drug. More...

A new artificial intelligence (AI)-based method has been developed to address this issue, offering a more accurate way to group cancer patients based on similar characteristics before treatment and similar outcomes after treatment. This method, detailed in a study published in Nature Communications, demonstrated that its ability to predict treatment outcomes from health record data surpassed the performance of any previous method. The approach holds the potential to improve patient selection in clinical trials and enable more personalized treatment choices for individual patients.

Machine learning has been a promising tool for detecting subtle yet meaningful patterns in large datasets, including those in the medical field. However, while machine learning systems can categorize patients into groups based on shared health data, these groupings do not always correlate closely with the patients’ subsequent responses to treatment. To improve this, researchers at Weill Cornell Medicine (New York, NY, USA) in collaboration with Regeneron Pharmaceuticals (Tarrytown, NY, USA), sought to develop a platform capable of sorting patients with the same disease receiving identical treatments into groups that share both baseline characteristics and treatment outcomes. The platform was trained on deidentified health records from 3,225 lung cancer patients in a commercial database, with each record containing 104 variables, including blood test results, medical history, prescriptions, and tumor stage.

The researchers tested this method using a real-world database of patients with advanced small cell lung cancer who were treated with immune checkpoint inhibitors. In this initial test, the platform grouped patients into three distinct categories. The group with the longest mean overall survival time from the beginning of treatment consisted mostly of women (55.5%) and had relatively low rates of other conditions such as diabetes and heart failure. In contrast, the group with the shortest survival time had less than half the mean survival time of the first group, was predominantly male (66.2%), and showed higher rates of tumor metastases along with abnormal blood tests indicating issues such as liver, kidney, and inflammatory problems.

Using a metric known as the concordance index, the researchers demonstrated that this new method outperformed standard statistical and machine learning techniques in predicting patient survival times. When the machine learning system was applied to a new dataset of 1,441 patients with non-small-cell lung cancer, it produced similar groupings of patients in terms of baseline characteristics and survival outcomes. Moving forward, the team plans to continue developing and testing this method for patient stratification in clinical trials for new drugs, as well as for selecting the most appropriate treatments for individual patients. Their platform’s ability to reliably group patients according to outcomes also suggests it could provide valuable insights into disease biology.

“We’re hopeful that this approach ultimately will be useful for testing and targeting treatments across a wide range of diseases,” said senior author Dr. Fei Wang. “We’ll probably need more than electronic health record data for this, but we do want to understand the biological mechanisms that explain these distinct patient subgroups.”

Related Links:
Weill Cornell Medicine
Regeneron Pharmaceuticals


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image Credit: Shutterstock

Explainable AI Examines Sepsis Mortality Risk and Emergency Care Delays

Preventing sepsis-related deaths in emergency departments (EDs) remains challenging because patient deterioration can result from multiple rapidly evolving and interconnected factors. These include triage... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: A new automated approach could help predict which patients with dystonia will benefit from deep brain stimulation before surgery (Image Credit: Adobe Stock)

AI Uses Routine MRI to Predict Deep Brain Stimulation Response in Dystonia

Dystonia is a debilitating neurological movement disorder characterized by involuntary muscle contractions that cause abnormal movements and postures. Deep brain stimulation (DBS) is one of the few treatments... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.